Summary & Overview
CPT 61600: Surgical Excision of Lesions at Anterior Cranial Fossa Base
CPT code 61600 is a critical billing code for the surgical resection or excision of neoplastic, vascular, or infectious lesions at the base of the anterior cranial fossa. This procedure is a cornerstone in the management of complex cranial pathologies, often necessitating advanced neurosurgical techniques and multidisciplinary collaboration. The code is most commonly utilized in inpatient hospital settings, reflecting the intensive nature of the surgery and the need for comprehensive postoperative care.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare, recognize and reimburse for CPT code 61600. This publication provides an overview of payer coverage, clinical indications, and policy benchmarks relevant to this procedure. Readers will gain insight into the clinical context, typical sites of service, and associated coding practices, including common modifiers and related codes. The summary also highlights the importance of accurate coding for reimbursement and compliance, as well as recent policy updates impacting skull base surgical procedures.
Healthcare professionals, administrators, and policy analysts will find this resource valuable for understanding the national landscape of CPT code 61600, including payer trends, clinical benchmarks, and regulatory considerations.
CPT Code Overview
CPT code 61600 describes the resection or excision of neoplastic, vascular, or infectious lesions located at the base of the anterior cranial fossa. This procedure is classified as a definitive skull base surgical intervention, typically performed in an inpatient hospital setting (Place of Service 21). The code is used to capture complex neurosurgical operations addressing a range of pathologies affecting the anterior cranial fossa, requiring specialized surgical expertise and multidisciplinary care.
Clinical & Coding Specifications
Clinical Context
A patient presents with symptoms such as persistent headaches, neurological deficits, or seizures. Imaging studies reveal a lesion at the base of the anterior cranial fossa, which may be neoplastic, vascular, or infectious in nature. After multidisciplinary evaluation, the patient is scheduled for definitive surgical resection or excision of the lesion. The procedure is performed in an inpatient hospital setting, often requiring collaboration between neurosurgeons and other surgical specialists. Postoperative care includes monitoring for complications and follow-up imaging to assess for residual disease.
Coding Specifications
-
Modifier
62(Two Surgeons): Used when two surgeons from different specialties (e.g., neurosurgery and otolaryngology) perform distinct parts of the procedure. -
Modifier
80(Assistant Surgeon): Applied when an assistant surgeon is required to support the primary surgeon during the operation.
| Provider Taxonomy Code | Specialty Name |
|---|---|
207T00000X | Neurological Surgery |
207X00000X | Orthopaedic Surgery |
208600000X | Surgery |
Related Diagnoses
-
C71.9- Malignant neoplasm of brain, unspecified- Indicates a cancerous lesion requiring surgical excision at the base of the anterior cranial fossa.
-
D33.0- Benign neoplasm of brain, supratentorial- Refers to a non-cancerous tumor in the supratentorial region, which may necessitate resection if symptomatic or growing.
-
I67.1- Cerebral aneurysm, nonruptured- Represents a vascular abnormality that may be treated surgically if located at the base of the anterior cranial fossa.
-
G93.5- Compression of brain- Used when a lesion causes mass effect or compression, justifying surgical intervention.
-
A87.9- Viral meningitis, unspecified- Relevant if infectious lesions at the cranial base are present and require excision as part of treatment.
Related CPT Codes
61601: Removal of intradural vascular or infectious neoplasm at base of anterior cranial fossa; repair any tear in the dura with or without graft
Clinical Relationship:
61601is closely related to61600and may be used when the lesion involves the intradural space and requires dural repair. It is an alternative or adjunct procedure depending on the extent and location of the lesion. These codes are not typically billed together for the same lesion but may be considered in complex cases involving both extradural and intradural pathology.
National Reimbursement Benchmarks
UnitedHealth Group has the highest national mean rate for CPT code 61600 at $3,810.89, while Medicare's mean rate is $1,944.80. The average commercial benchmark (BUCA) stands at $2,728.24, which is notably higher than Medicare but lower than the top commercial payers.
Rate dispersion varies significantly across payers. Medicare shows the tightest range between the 75th and 25th percentiles ($2,009.00 - $1,859.00 = $150.00), indicating less variability in rates. In contrast, UnitedHealth Group exhibits the widest spread ($4,629.00 - $2,410.00 = $2,219.00), reflecting substantial rate variation. Cigna and Blue Cross Blue Shield also display broad ranges, while Aetna and BUCA are more moderate.
The table and chart below present a detailed breakdown of national mean rates and percentile values for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.